• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

Analysis of the differentiation control factor of leukemia, PRDM16 and physiological inhibitor LR11

Research Project

Project/Area Number 24591380
Research Category

Grant-in-Aid for Scientific Research (C)

Allocation TypeMulti-year Fund
Section一般
Research Field Hematology
Research InstitutionToho University (2014)
Chiba University (2012-2013)

Principal Investigator

SHIMIZU Naomi  東邦大学, 医学部, 講師 (30375802)

Project Period (FY) 2012-04-01 – 2015-03-31
Project Status Completed (Fiscal Year 2014)
Budget Amount *help
¥5,330,000 (Direct Cost: ¥4,100,000、Indirect Cost: ¥1,230,000)
Fiscal Year 2014: ¥1,300,000 (Direct Cost: ¥1,000,000、Indirect Cost: ¥300,000)
Fiscal Year 2013: ¥1,170,000 (Direct Cost: ¥900,000、Indirect Cost: ¥270,000)
Fiscal Year 2012: ¥2,860,000 (Direct Cost: ¥2,200,000、Indirect Cost: ¥660,000)
KeywordsLR11 / G-CSF / 白血病 / 転写因子 / プロテアーゼ / WT1 / GATA1 / GATA2 / CD71
Outline of Final Research Achievements

We reported that LR11 is highly expressed in blasts of leukemia cells and the soluble form of LR11 (sLR11) is a modifier of leukemic cell migration. Moreover, the sLR11 levels are elevated by G-CSF. We evaluated the relation between transcriptional factors which regulate differentiation mechanism and LR11 under this background. It was not observed apparent association between the nuclear transcription factor and LR11. However, G-CSF, an important cytokine in the differentiation process, increased the TNF-α with soluble LR11 in leukemic cell lines. These results revealed the involvement of protease activation in the mechanism. The transcriptional factors which localize to cell membrane may be activated by proteases and play a key role in the relation between the transcription factors and LR11.

Report

(4 results)
  • 2014 Annual Research Report   Final Research Report ( PDF )
  • 2013 Research-status Report
  • 2012 Research-status Report
  • Research Products

    (12 results)

All 2015 2014 2013 2012

All Journal Article (8 results) (of which Peer Reviewed: 8 results,  Open Access: 5 results) Presentation (4 results)

  • [Journal Article] Serum soluble LR11, a novel tumor derived biomarker associated with the outcome of patients with diffuse large B-cell lymphoma.2015

    • Author(s)
      Ohwada C, Yamazaki A, Kawaguchi T, Sugita Y, Takeuchi M, Shimizu N, Sakaida E, Takeda Y, Tsukamoto S, Muto T, Jiang M, Higashi M, Yokote K, Tamaru JI, Bujo H, Nakaseko C.
    • Journal Title

      Leuk Lymphoma.

      Volume: 印刷中 Issue: 10 Pages: 1-4

    • DOI

      10.3109/10428194.2015.1016930

    • Related Report
      2014 Annual Research Report
    • Peer Reviewed / Open Access
  • [Journal Article] G-CSF induces the release of the soluble form of LR11, a regulator of myeloid cell mobilization in bone marrow2014

    • Author(s)
      Shimizu N, Nakaseko C, Jiang M, Nishii K, Yokote K, Iseki T, Higashi M, Tamaru J, Schneider WJ, Bujo H
    • Journal Title

      Ann Hematol

      Volume: (印刷中) Issue: 7 Pages: 1111-1122

    • DOI

      10.1007/s00277-014-2033-0

    • Related Report
      2014 Annual Research Report 2013 Research-status Report
    • Peer Reviewed / Open Access
  • [Journal Article] Tetraspanin CD9 modulates ADAM17-mediated shedding of LR11 in leukocytes.2014

    • Author(s)
      Tsukamoto S, Takeuchi M, Kawaguchi T, Togasaki E, Yamazaki A, Sugita Y, Muto T, Sakai S, Takeda Y, Ohwada C, Sakaida E, Shimizu N, Nishii K, Jiang M, Yokote K, Bujo H, Nakaseko C.
    • Journal Title

      Exp Mol Med.

      Volume: - Issue: 4 Pages: 46-89

    • DOI

      10.1038/emm.2013.161

    • Related Report
      2014 Annual Research Report
    • Peer Reviewed / Open Access
  • [Journal Article] Potential utility of serum soluble LR11 as a diagnostic biomarker for intravascular large B-cell lymphoma2014

    • Author(s)
      Kawaguchi T, Ohwada C, Takeuchi M, Shimizu N, Sakaida E, Takeda Y, Sakai S, Tsukamoto S, Yamazaki A, Sugita Y, Higashi M, Fujikawa K, Matsue K, Yokote K, Tamaru JI, Bujo H, Nakaseko C
    • Journal Title

      Leuk Lymphoma

      Volume: (印刷中) Issue: 10 Pages: 2391-2394

    • DOI

      10.3109/10428194.2014.880430

    • Related Report
      2014 Annual Research Report 2013 Research-status Report
    • Peer Reviewed / Open Access
  • [Journal Article] Circulating LR11 is a novel soluble-receptor marker for early-stage clinical conditions in patients with non-Hodgkin's lymphoma.2014

    • Author(s)
      Fujimura K, Ebinuma H, Fukamachi I, Ohwada C, Kawaguchi T, Shimizu N, Takeuchi M, Sakaida E, Jiang M, Nakaseko C, Bujo H.
    • Journal Title

      Clin Chim Acta.

      Volume: 430 Pages: 48-54

    • DOI

      10.1016/j.cca.2013.12.039

    • Related Report
      2014 Annual Research Report 2013 Research-status Report
    • Peer Reviewed / Open Access
  • [Journal Article] LR11 : a novel biomarker identified in follicular lymphoma2013

    • Author(s)
      Kawaguchi T, Ohwada C, Takeuchi M, Shimizu N, Sakaida E, Takeda Y, Sakai S, Tsukamoto S, Yamazaki A, Sugita Y, Jiang M, Higashi M, Yokote K, Tamura J, Bujo H, Nakaseko C
    • Journal Title

      Br J Haematol

      Volume: 163(2) Issue: 2 Pages: 277-280

    • DOI

      10.1111/bjh.12467

    • Related Report
      2013 Research-status Report
    • Peer Reviewed
  • [Journal Article] The soluble form of LR11 is a regulator of hypoxia-induced, uPAR-mediated adhesion of immature hematological cells2013

    • Author(s)
      Keigo Nishii, Chiaki Nakaseko, Meizi Jiang, Naomi Shimizu, Masahiro Takeuchi, Wolfgang Johann Schneider, and Hideaki Bujo
    • Journal Title

      The Journal of Biological Chemistry

      Volume: 288(17) Issue: 17 Pages: 11877-11886

    • DOI

      10.1074/jbc.m112.442491

    • Related Report
      2013 Research-status Report
    • Peer Reviewed
  • [Journal Article] Circulating soluble LR11/SorLA levels are highly increased and ameliorated by chemotherapy in acute leukemias2012

    • Author(s)
      Sakai S, Nakaseko C, Takeuchi M, Ohwada C, Shimizu N, Tsukamoto S, Kawaguchi T, Jiang M, Sato Y, Ebinuma H, Yokote K, Iwama A, Fukamachi I, Schneider WJ, Saito Y, Bujo H.
    • Journal Title

      Clin Chim Acta

      Volume: 96 Issue: 19-20 Pages: 542-1548

    • DOI

      10.1016/j.cca.2012.06.025

    • Related Report
      2012 Research-status Report
    • Peer Reviewed
  • [Presentation] Tetraspanin CD9 inhibited ADAM17-mediated LR11 shedding in leukemia cell lines.2013

    • Author(s)
      Shokichi Tsukamoto, Masahiro Takeuchi, Takeharu Kawaguchi, Emi Togasaki, Atsuko Yamazaki, Yasumasa Sugita, Tomoya Muto, Shio Sakai, Yusuke Takeda, Chikako Ohwada, Naomi Shimizu, Emiko Sakaida, Keigo Nishii, Jiang Meizi, Tohru Iseki, Koutaro Yokote, Hideaki Bujo, Chiaki Nakaseko.
    • Organizer
      The 55rd Annual Meeting og the American Society of Hematology
    • Place of Presentation
      New Orleans(USA)
    • Related Report
      2013 Research-status Report
  • [Presentation] Soluble form of LR11 is highly espressed on myeloid cells after G-CSF treatment.2012

    • Author(s)
      Naomi Shimizu, Hideaki Bujo, Shio Sakai, Shokichi Tsukamoto, Takeharu Kawaguchi, Yusuke Takeda, Chikako Ohwada, Masahiro Takeuchi, Emiko Sakaida, Keigo Nishi, Meizi Jiang, Chiaki Nakaseko.
    • Organizer
      The 74th Annual Meeting of the Japanese Society of Hematology
    • Place of Presentation
      京都国際会館
    • Related Report
      2012 Research-status Report
  • [Presentation] Tetraspanin CD9 regulates ADAM17-mediated LR11 shedding in leukemia cells.2012

    • Author(s)
      Shokichi Tsukamoto, Masahiro Takeuchi, Atsuko Yamazaki, Takeharu Kawaguchi, Chikako Ohwada, Naomi Shimizu, Emiko Sakaida, Keigo Nishi, Meizi Jiang, Hideaki Bujo, Chiaki Nakaseko.
    • Organizer
      The 74th Annual Meeting of the Japanese Society of Hematology
    • Place of Presentation
      京都国際会館
    • Related Report
      2012 Research-status Report
  • [Presentation] Soluble LR11, a novel acute leukemia marker, drastically induces WT1 mRNA expression together with synergic activation of GATAs, and the migration activity.2012

    • Author(s)
      Naomi Shimizu, Chiaki Nakaseko, Masahiro Takeuchi, Chikako Ohwada, Shokichi Tsukamoto, Keigo Nishii, Meiji Jiang, Koutaro Yokote, Isamu Fukamachi, Hideaki Bujo.
    • Organizer
      The 53rd Annual Meeting of the American Society of Hematology
    • Place of Presentation
      Atlanta(USA)
    • Related Report
      2012 Research-status Report

URL: 

Published: 2013-05-31   Modified: 2019-07-29  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi